Cost-Effectiveness of Biological Therapy in Remission Induction of Moderate to Severe Plaque Psoriasis

Publisher： Karger

E-ISSN： 1421-9832|221|3|236-242

ISSN： 1018-8665

Source： Dermatology, Vol.221, Iss.3, 2010-10, pp. : 236-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study

By  

Dermatology, Vol. 212, Iss. 2, 2006-03 ,pp. : 137-144

Karger

Access to resources Recommend Favorite

Cost-Effectiveness Model of Topical Treatment of Mild to Moderate Psoriasis Vulgaris in Germany

By  

Dermatology, Vol. 215, Iss. 3, 2007-09 ,pp. : 219-228

Karger

Access to resources Recommend Favorite

Relationship between Clinical Response to Therapy and Health-Related Quality of Life Outcomes in Patients with Moderate to Severe Plaque Psoriasis

By  

Dermatology, Vol. 216, Iss. 3, 2008-01 ,pp. : 260-270

Karger

Access to resources Recommend Favorite

Mild Cognitive Impairment in Patients with Moderate to Severe Chronic Plaque Psoriasis

By  

Dermatology, Vol. 228, Iss. 1, 2014-01 ,pp. : 78-85

Karger

Access to resources Recommend Favorite

Patients with Moderate to Severe Plaque Psoriasis: One Year after the European Medicines Agency Recommendation of Efalizumab Suspension

By  

Dermatology, Vol. 222, Iss. 3, 2011-04 ,pp. : 250-255

Karger

Access to resources Recommend Favorite